BioMerieux Finalizes BioFire Diagnostics Acquisition | GenomeWeb

NEW YORK (GenomeWeb News) — BioMérieux said today that it has finalized its acquisition of in BioFire Diagnostics, giving it 100 percent ownership of the company.

BioMérieux, based in Marcy l'Etoile, France, first announced the agreement to purchase Salt Lake City, Utah-based BioFire in September.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.